Mineralys Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$170.6 | -$192.4 | -$84.7 | -$31.5 | — |
| Net income | -$154.7 | -$177.8 | -$71.9 | -$29.8 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$142.4 | -$166.4 | -$81.2 | — | — |
Shares outstanding 82.5M · Free float 64.4%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.